Democratizing Biologics: The Cost-Saving Revolution in the Global Biosimilars Market
The rise of biological medicines has been a miracle for patients with cancer, autoimmune diseases, and rare disorders. However, these complex, large-molecule drugs are incredibly expensive to manufacture, leading to price tags that threaten the sustainability of healthcare systems. Enter biosimilars—lower-cost versions of these biologics that are highly similar in safety and efficacy. As...
0 Comments 0 Shares 129 Views 0 Reviews